BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29327178)

  • 21. Preoperative Geriatric Nutritional Risk Index: A predictive and prognostic factor in patients with pathological stage I non-small cell lung cancer.
    Shoji F; Matsubara T; Kozuma Y; Haratake N; Akamine T; Takamori S; Katsura M; Toyokawa G; Okamoto T; Maehara Y
    Surg Oncol; 2017 Dec; 26(4):483-488. PubMed ID: 29113668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early Skeletal Muscle Loss in Non-Small Cell Lung Cancer Patients Receiving Chemoradiation and Relationship to Survival.
    Kiss N; Beraldo J; Everitt S
    Support Care Cancer; 2019 Jul; 27(7):2657-2664. PubMed ID: 30478673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of low skeletal muscle mass and density on short and long-term outcome after resection of stage I-III colorectal cancer.
    van Vugt JLA; Coebergh van den Braak RRJ; Lalmahomed ZS; Vrijland WW; Dekker JWT; Zimmerman DDE; Vles WJ; Coene PLO; IJzermans JNM
    Eur J Surg Oncol; 2018 Sep; 44(9):1354-1360. PubMed ID: 29914788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different computed tomography parameters for defining myosteatosis in patients with advanced non-small cell lung cancer.
    Zhang W; Tang J; Tang H; Xie L; Wang J; Wu J; Yang M
    Clin Nutr; 2023 Dec; 42(12):2414-2421. PubMed ID: 37871482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative pulmonary function as a prognostic factor for stage I non-small cell lung carcinoma.
    Iizasa T; Suzuki M; Yasufuku K; Iyoda A; Otsuji M; Yoshida S; Sekine Y; Shibuya K; Saitoh Y; Hiroshima K; Fujisawa T
    Ann Thorac Surg; 2004 Jun; 77(6):1896-902; discussion 1902-3. PubMed ID: 15172232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of preoperative evaluation of skeletal muscle index and immune-nutritional status for patients with early-stage non-small cell lung cancer.
    Sato S; Sato M; Shinohara H
    Gen Thorac Cardiovasc Surg; 2023 Jun; 71(6):354-362. PubMed ID: 36562876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Preoperative Controlling Nutritional Status Score Predicts Survival After Curative Surgery in Patients with Pathological Stage I Non-small Cell Lung Cancer.
    Shoji F; Haratake N; Akamine T; Takamori S; Katsura M; Takada K; Toyokawa G; Okamoto T; Maehara Y
    Anticancer Res; 2017 Feb; 37(2):741-747. PubMed ID: 28179325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sarcopenia predicts poor postoperative outcome in elderly patients with lung cancer.
    Kawaguchi Y; Hanaoka J; Ohshio Y; Okamoto K; Kaku R; Hayashi K; Shiratori T; Yoden M
    Gen Thorac Cardiovasc Surg; 2019 Nov; 67(11):949-954. PubMed ID: 30972530
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low paravertebral muscle mass in patients with bone metastases from lung cancer is associated with poor prognosis.
    Dohzono S; Sasaoka R; Takamatsu K; Hoshino M; Nakamura H
    Support Care Cancer; 2020 Jan; 28(1):389-394. PubMed ID: 31055666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased adipose tissue is associated with improved overall survival, independent of skeletal muscle mass in non-small cell lung cancer.
    Tao J; Fang J; Chen L; Liang C; Chen B; Wang Z; Wu Y; Zhang J
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2591-2601. PubMed ID: 37724690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder.
    Miyake M; Morizawa Y; Hori S; Marugami N; Shimada K; Gotoh D; Tatsumi Y; Nakai Y; Inoue T; Anai S; Torimoto K; Aoki K; Tanaka N; Fujimoto K
    BMC Cancer; 2017 Mar; 17(1):237. PubMed ID: 28359307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of skeletal muscle mass for immunotherapy with nivolumab in non-small cell lung cancer patients: A "hypothesis-generator" preliminary report.
    Cortellini A; Verna L; Porzio G; Bozzetti F; Palumbo P; Masciocchi C; Cannita K; Parisi A; Brocco D; Tinari N; Ficorella C
    Thorac Cancer; 2019 Feb; 10(2):347-351. PubMed ID: 30600905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Respiratory strength and pectoralis muscle mass as measures of sarcopenia: Relation to outcomes in resected non-small cell lung cancer.
    Sun C; Anraku M; Kawahara T; Karasaki T; Kitano K; Nagayama K; Sato M; Nakajima J
    J Thorac Cardiovasc Surg; 2022 Mar; 163(3):779-787.e2. PubMed ID: 33317785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term survival after lobectomy for non-small cell lung cancer by video-assisted thoracic surgery versus thoracotomy.
    Lee PC; Nasar A; Port JL; Paul S; Stiles B; Chiu YL; Andrews WG; Altorki NK
    Ann Thorac Surg; 2013 Sep; 96(3):951-60; discussion 960-1. PubMed ID: 23866808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
    Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical utility of psoas muscle volume in assessment of sarcopenia in patients with early-stage non-small cell lung cancer.
    Yamada Y; Shimada Y; Makino Y; Kudo Y; Maehara S; Yamada T; Hagiwara M; Kakihana M; Ohira T; Ikeda N
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3277-3285. PubMed ID: 35916994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does sarcopenia have any impact on survival of patients with surgically treated non-small-cell lung cancer?
    Deng HY; Zha P; Hou L; Huang KL
    Interact Cardiovasc Thorac Surg; 2019 Jul; 29(1):144-147. PubMed ID: 30843065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sarcopenia is an independent unfavorable prognostic factor of non-small cell lung cancer after surgical resection: A comprehensive systematic review and meta-analysis.
    Deng HY; Hou L; Zha P; Huang KL; Peng L
    Eur J Surg Oncol; 2019 May; 45(5):728-735. PubMed ID: 30348603
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computed Tomography-Assessed Skeletal Muscle Mass as a Predictor of Outcomes in Lung Cancer Surgery.
    Nishimura JM; Ansari AZ; D'Souza DM; Moffatt-Bruce SD; Merritt RE; Kneuertz PJ
    Ann Thorac Surg; 2019 Nov; 108(5):1555-1564. PubMed ID: 31228408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of radiodensity-based skeletal muscle quantification using preoperative CT in resected non-small cell lung cancer.
    Kim EY; Kim YJ; Kim YS; Kim KW; Jeon JY; Kim KG
    J Thorac Dis; 2021 Feb; 13(2):754-761. PubMed ID: 33717547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.